Company
Progyny, Inc.
Headquarters: New York, NY, United States
Employees: 311
CEO: Mr. Peter Anevski
Market Cap
$3.47 Billion
USD as of Jan. 1, 2024
Progyny, Inc. Categories
United States Healthcare Health Information ServicesUnited States Healthcare United States Health Information Services
Top Competitors by Market Capitalization
Industry: Health Information Services
| Company | Market Cap (USD) |
|---|---|
| GE HealthCare | $34.86 B |
| Veeva Systems Inc. | $29.97 B |
| M3, Inc. | $11.24 B |
| Change Healthcare Inc. | $9.03 B |
| Signify Health, Inc. | $8.38 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Progyny, Inc. has the following listings and related stock indices.
Stock: NASDAQ: PGNY wb_incandescent